Stock Price & Analysis

Based on the latest data and market conditions, here's a concise analysis for CBOE stock:

Technical Analysis The stock is currently trading at $209.71, showing a decline of -0.69% in regular market hours. The RSI of 66.48 indicates the stock is approaching but not yet in overbought territory. With the price above both 20-day SMA ($201.17) and 60-day SMA ($201.76), the overall trend remains bullish.

Recent Developments

• Cboe reported Q4 2024 results with net revenue growing 5% year-over-year to $524.5 million
• The company announced plans to launch 24-hour trading for U.S. equities on EDGX Exchange to meet growing global investor demand
• Management provided 2025 guidance expecting mid-single digit organic net revenue growth

Analyst Sentiment Recent analyst actions have been mixed:

• Oppenheimer raised price target to $233, maintaining Outperform rating
• Barclays lowered target to $216 from $220, maintaining Equal Weight rating
• The average analyst price target stands at $208.25

Recommendation: SELL at current levels around $209.71. While CBOE shows strong fundamentals and positive business developments, the stock is trading above analyst consensus targets and technical indicators suggest it's approaching overbought territory. Consider re-entering at lower levels closer to the 20-day SMA of $201.17.

Based on the provided data and recent market developments, here's a comprehensive price prediction for CBOE stock in 2025:

Technical Analysis The stock is currently trading at $209.71, showing a mixed technical picture with RSI at 66.48 indicating approaching overbought conditions but still room for upside. The stock is trading above its 20-day moving average of $201.17, suggesting positive short-term momentum.

Fundamental Drivers Recent Q4 2024 earnings showed solid performance with 5% revenue growth to $524.5 million. The company's strategic focus on derivatives business and Data Vantage segment positions it well for 2025. Management has guided for mid-single-digit organic revenue growth in 2025.

Analyst Sentiment Oppenheimer recently raised their price target to $233 from $218, citing solid Q4 results and potential merger speculation with CME. However, Barclays maintains a more conservative target of $216.

Price Prediction for 2025 Based on technical indicators, fundamental growth outlook and analyst consensus, CBOE stock is expected to reach $225-230 by end of 2025, representing about 7-10% upside from current levels. This projection is supported by the company's strong market position in derivatives trading, growing Data Vantage business, and potential M&A opportunities.

The S1 support level for CBOE Stock is $202.47 ,The R1 resistant level for CBOE Stock is $214.56.

As of the end of day on 2025-02-11, the price of CBOE Stock was $207.8.

The target price for CBOE Stock according to analyst rating is 206.00, with the highest price target at 224.00 and the lowest at 174.00. Analysts have a Hold rating on CBOE Stock overall.

The market cap of CBOE is $21.8B.

Based on the provided data and recent market information, I'll analyze whether CBOE is overvalued through multiple valuation metrics and recent performance.

Valuation Analysis: CBOE's current P/E ratio of 27.09x is relatively high compared to its historical average, suggesting a premium valuation. The EV/EBITDA of 15.86x in Q4 2024 indicates the company is trading at a moderate premium to its peers in the exchange sector.

Financial Performance: Net revenue grew 5% year-over-year to $524.5 million in Q4 2024, while adjusted EPS increased by 2% to $2.10, slightly missing analyst estimates. The company demonstrated strong organic growth across segments, particularly in cash and spot markets (+14%) and Data Vantage (+8%).

Growth and Market Position: CBOE achieved record volumes in 2024, with SPX options reaching 3.1 million contracts ADV and VIX options hitting 830,000 contracts ADV. The company's expansion into retail through Robinhood and international markets, particularly in APAC, positions it well for future growth.

Market Sentiment: The stock has crossed above the average analyst target price of $208.25, with analysts having targets ranging from $174 to $245, indicating mixed views on valuation. Recent analyst actions have been cautious, with JPMorgan downgrading the stock.

Conclusion: CBOE appears moderately overvalued at current levels based on traditional metrics and recent price appreciation. While the company shows strong operational execution and growth potential, the premium valuation and recent analyst downgrades suggest limited upside potential in the near term.

Based on the available data and market analysis, here's a price prediction for CBOE stock by 2030:

CBOE stock is projected to reach approximately $350-375 by 2030, driven by continued growth in its derivatives business and global expansion initiatives. The company's strong market position in index options trading, particularly with SPX and VIX products, combined with its strategic focus on retail adoption and international growth in Asia Pacific markets, supports this bullish outlook. Recent analyst upgrades, including Oppenheimer's increased price target to $233, and the company's consistent execution of its strategic initiatives provide confidence in this long-term target.